Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — February 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

IRONWOOD PHARMACEUTICALS INC (IRWD)

Gaskins Tammi L — Chief Commercial Officer
Feb 24, 2026
Sale
Shares
11,239
Price
$3.66
Total Value
$41.13K
Shares Held After
213,738
% of Holdings
5.0%

IRONWOOD PHARMACEUTICALS INC (IRWD)

Silver Ronald — Principal Accounting Officer
Feb 24, 2026
Sale
Shares
12,621
Price
$3.66
Total Value
$46.19K
Shares Held After
252,636
% of Holdings
4.8%
Feb 24, 2026
Purchase
Shares
20,000
Price
$1.00
Total Value
$19.95K
Shares Held After
1,908,551
% of Holdings
1.0%

IRONWOOD PHARMACEUTICALS INC (IRWD)

John Minardo — Chief Legal Officer
Feb 24, 2026
Sale
Shares
19,053
Price
$3.66
Total Value
$69.73K
Shares Held After
363,886
% of Holdings
5.0%

ARDELYX, INC. (ARDX)

RAAB MICHAEL — Director
Feb 24, 2026
Sale
Shares
41,666
Price
$6.25
Total Value
$260.62K
Shares Held After
1,836,153
% of Holdings
2.2%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
15,771
Price
$156.53
Total Value
$2.47M
Shares Held After
51,871
% of Holdings
23.3%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
4,151
Price
$155.06
Total Value
$643.65K
Shares Held After
67,642
% of Holdings
5.8%

INSMED Inc (INSM)

Smith Michael Alexander — Chief Legal Officer
Feb 24, 2026
Sale
Shares
4,852
Price
$153.93
Total Value
$746.87K
Shares Held After
71,793
% of Holdings
6.3%

IRONWOOD PHARMACEUTICALS INC (IRWD)

Martini Gregory S. — Chief Financial Officer
Feb 24, 2026
Sale
Shares
11,457
Price
$3.66
Total Value
$41.93K
Shares Held After
160,601
% of Holdings
6.7%

Caribou Biosciences, Inc. (CRBU)

Kelly Timothy P — Chief Technology Officer
Feb 24, 2026
Sale
Shares
3,147
Price
$1.96
Total Value
$6.17K
Shares Held After
79,353
% of Holdings
3.8%

Caribou Biosciences, Inc. (CRBU)

Khan Ruhi Ahmad — Chief Business Officer
Feb 24, 2026
Sale
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
104,998
% of Holdings
6.2%

Caribou Biosciences, Inc. (CRBU)

MCCLUNG BARBARA G — Chief Legal Officer
Feb 24, 2026
Sale
Shares
6,938
Price
$1.96
Total Value
$13.60K
Shares Held After
481,564
% of Holdings
1.4%

Caribou Biosciences, Inc. (CRBU)

Albertson Tina M. — Chief Medical Officer
Feb 24, 2026
Sale
Shares
1,066
Price
$1.96
Total Value
$2.09K
Shares Held After
68,523
% of Holdings
1.5%
Feb 24, 2026
Sale
Shares
736
Price
$18.15
Total Value
$13.36K
Shares Held After
325,059
% of Holdings
0.2%

SERA PROGNOSTICS, INC. (SERA)

Harrison Robert Gardner — Chief Information Officer
Feb 24, 2026
Sale
Shares
2,000
Price
$2.34
Total Value
$4.68K
Shares Held After
80,788
% of Holdings
2.4%
Feb 23, 2026
Sale
Shares
11,656
Price
$1.45
Total Value
$16.90K
Shares Held After
61,750
% of Holdings
15.9%
Feb 23, 2026
Sale
Shares
8,541
Price
$1.45
Total Value
$12.38K
Shares Held After
88,188
% of Holdings
8.8%
Feb 23, 2026
Purchase
Shares
550,458
Price
$5.45
Total Value
$3.00M
Shares Held After
2,763,527
% of Holdings
19.9%

Vera Therapeutics, Inc. (VERA)

Skelton Laurence Matthew — Chief Commercial Officer
Feb 23, 2026
Sale
Shares
1,582
Price
$41.98
Total Value
$66.42K
Shares Held After
64,218
% of Holdings
2.4%

Vera Therapeutics, Inc. (VERA)

Brenner Robert — Chief Medical Officer
Feb 23, 2026
Sale
Shares
2,151
Price
$41.98
Total Value
$90.31K
Shares Held After
50,947
% of Holdings
4.1%

Vera Therapeutics, Inc. (VERA)

Grant Sean — CHIEF FINANCIAL OFFICER
Feb 23, 2026
Sale
Shares
4,949
Price
$41.98
Total Value
$207.78K
Shares Held After
114,181
% of Holdings
4.2%

Vera Therapeutics, Inc. (VERA)

Turner William D. — Chief Regulatory Officer
Feb 23, 2026
Sale
Shares
2,187
Price
$41.98
Total Value
$91.82K
Shares Held After
45,313
% of Holdings
4.6%

Vera Therapeutics, Inc. (VERA)

JOHNSON DAVID LEE — Chief Operating Officer
Feb 23, 2026
Sale
Shares
2,579
Price
$41.98
Total Value
$108.28K
Shares Held After
45,727
% of Holdings
5.3%

Vera Therapeutics, Inc. (VERA)

Young Joseph R — SVP, FINANCE, CHIEF ACCT OFFCR
Feb 23, 2026
Sale
Shares
3,117
Price
$41.98
Total Value
$130.86K
Shares Held After
64,722
% of Holdings
4.6%
Feb 23, 2026
Sale
Shares
16,925
Price
$41.98
Total Value
$710.58K
Shares Held After
257,163
% of Holdings
6.2%
Feb 23, 2026
Sale
Shares
20,056
Price
$8.28
Total Value
$166.06K
Shares Held After
3,013,022
% of Holdings
0.7%

OCULAR THERAPEUTIX, INC (OCUL)

Heier Jeffrey S. — Chief Scientific Officer
Feb 23, 2026
Sale
Shares
3,057
Price
$8.28
Total Value
$25.31K
Shares Held After
323,368
% of Holdings
0.9%

OCULAR THERAPEUTIX, INC (OCUL)

Kaiser Peter — Chief Development Officer
Feb 23, 2026
Sale
Shares
2,810
Price
$8.28
Total Value
$23.27K
Shares Held After
269,108
% of Holdings
1.0%

OCULAR THERAPEUTIX, INC (OCUL)

Nayak Sanjay — Chief Strategy Officer
Feb 23, 2026
Sale
Shares
1,759
Price
$8.28
Total Value
$14.56K
Shares Held After
330,653
% of Holdings
0.5%

Scholar Rock Holding Corp (SRRK)

Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Feb 23, 2026
Sale
Shares
200
Price
$48.48
Total Value
$9.70K
Shares Held After
98,445
% of Holdings
0.2%

Scholar Rock Holding Corp (SRRK)

Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Feb 23, 2026
Sale
Shares
857
Price
$47.86
Total Value
$41.01K
Shares Held After
98,645
% of Holdings
0.9%

Scholar Rock Holding Corp (SRRK)

Qatanani Mo — CHIEF SCIENTIFIC OFFICER
Feb 23, 2026
Sale
Shares
7,427
Price
$46.94
Total Value
$348.64K
Shares Held After
99,502
% of Holdings
6.9%

ARTIVION, INC. (AORT)

Horton Amy — VP, Chief Accounting Officer
Feb 23, 2026
Sale
Shares
1,731
Price
$37.59
Total Value
$65.06K
Shares Held After
128,327
% of Holdings
1.3%

ARTIVION, INC. (AORT)

Davis John E — Chief Commercial Officer
Feb 23, 2026
Sale
Shares
3,773
Price
$37.59
Total Value
$141.82K
Shares Held After
190,943
% of Holdings
1.9%

ARTIVION, INC. (AORT)

Stanton Marshall S. — SVP, Clinical & MD Affair
Feb 23, 2026
Sale
Shares
2,423
Price
$37.59
Total Value
$91.08K
Shares Held After
43,180
% of Holdings
5.3%

ARTIVION, INC. (AORT)

Mackin James P — President & CEO
Feb 23, 2026
Sale
Shares
20,962
Price
$37.59
Total Value
$787.92K
Shares Held After
780,031
% of Holdings
2.6%

ARVINAS, INC. (ARVN)

Teel Randy — Director
Feb 23, 2026
Sale
Shares
3,748
Price
$12.16
Total Value
$45.58K
Shares Held After
149,696
% of Holdings
2.4%

ARTIVION, INC. (AORT)

Holloway Jean F — SVP, General Counsel
Feb 23, 2026
Sale
Shares
3,079
Price
$37.59
Total Value
$115.73K
Shares Held After
153,871
% of Holdings
2.0%

ARTIVION, INC. (AORT)

Berry Lance A — EVP, COO, CFO & Treasurer
Feb 23, 2026
Sale
Shares
4,981
Price
$37.59
Total Value
$187.23K
Shares Held After
148,450
% of Holdings
3.2%

ARVINAS, INC. (ARVN)

Teel Randy — Director
Feb 23, 2026
Sale
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
153,444
% of Holdings
0.7%

Ceribell, Inc. (CBLL)

Chao Xingjuan — Director
Feb 23, 2026
Sale
Shares
2,084
Price
$19.79
Total Value
$41.24K
Shares Held After
725,164
% of Holdings
0.3%

ARVINAS, INC. (ARVN)

Cacace Angela M — Chief Scientific Officer
Feb 23, 2026
Sale
Shares
2,571
Price
$12.16
Total Value
$31.26K
Shares Held After
147,623
% of Holdings
1.7%

ARVINAS, INC. (ARVN)

Cacace Angela M — Chief Scientific Officer
Feb 23, 2026
Sale
Shares
1,038
Price
$12.16
Total Value
$12.62K
Shares Held After
150,194
% of Holdings
0.7%

Ceribell, Inc. (CBLL)

Blumberg Scott — Chief Financial Officer
Feb 23, 2026
Sale
Shares
808
Price
$19.79
Total Value
$15.99K
Shares Held After
118,334
% of Holdings
0.7%

ARVINAS, INC. (ARVN)

Loomis David K — Chief Accounting Officer
Feb 23, 2026
Sale
Shares
1,108
Price
$12.16
Total Value
$13.47K
Shares Held After
29,692
% of Holdings
3.6%

Ceribell, Inc. (CBLL)

Foehr David — Senior VP, Finance and PAO
Feb 23, 2026
Sale
Shares
569
Price
$19.79
Total Value
$11.26K
Shares Held After
18,331
% of Holdings
3.0%

10x Genomics, Inc. (TXG)

Taich Adam — Chief Financial Officer
Feb 23, 2026
Sale
Shares
8,968
Price
$18.58
Total Value
$166.59K
Shares Held After
288,417
% of Holdings
3.0%
Feb 23, 2026
Sale
Shares
9,632
Price
$18.58
Total Value
$178.93K
Shares Held After
1,061,924
% of Holdings
0.9%
Feb 23, 2026
Sale
Shares
7,826
Price
$18.58
Total Value
$145.38K
Shares Held After
424,779
% of Holdings
1.8%

Cullinan Therapeutics, Inc. (CGEM)

Michaelson Jennifer — Chief Scientific Officer
Feb 23, 2026
Sale
Shares
1,752
Price
$13.99
Total Value
$24.51K
Shares Held After
180,225
% of Holdings
1.0%
Version: v26.3.24